Nephrotic syndrome; is rituximab the light at the end of the tunnel in the treatment of adult steroid-dependent minimal change disease and focal segmental glomerulosclerosis?
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | English |
| Argitaratua: |
Society of Diabetic Nephropathy Prevention
2014-01-01
|
| Saila: | Journal of Nephropathology |
| Gaiak: | |
| Sarrera elektronikoa: | https://nephropathol.com/PDF/jnp-3-1.pdf |